Competence Centre on Health Technologies
Follow us on

About Us

Who we are

Our Mission is to bring personalised medicine to every IFV patient. We see ourselves as an innovative research-based laboratory that contributes to patients’ well-being in partnership with IVF clinics worldwide. All team members value continuous research for improving the existing personalised medicine tests and finding better solutions.

Send an Email
Competence Centre on Health Technologies
(Tervisetehnoloogiate Arenduskeskus)
Teaduspargi 13, 50411 Tartu Estonia, European Union
Call us today
+372 733 0403
Kaarel Krjutškov, PhD
Kaarel Krjutškov, PhD
COO, Head of laboratory
Kadi Sagor
Kadi Sagor
Laboratory specialist
Susanna Janno
Susanna Janno
Laboratory specialist
Neeme Tõnisson M.D., PhD
Neeme Tõnisson M.D., PhD
Med Lab Doctor
Andres Salumets, PhD
Andres Salumets, PhD
Member of Board
Priit Palta, PhD
Priit Palta, PhD
Head of Bioinformatics
Külli Samuel
Külli Samuel
Logistics
Signe Mölder, MSc
Signe Mölder, MSc
Quality manager

The beREADY team

Our team consists of eminent researchers in their field – five members with a PhD and a doctor of medicine (MD). We collaborate with several leading universities in personalised and precision medicine, molecular biology, genetics and genomics. For example Karolinska Institutet, University of Helsinki, Leuven University, Oulu University, Granada University and others. In total, the we have published over 300 scientific articles and have applied for multiple international patents. We have successfully established IVF clinics and have been nominated for “Innovation of the Year” in Swedish business awards in 2016.

The Competence Centre on Health Technologies (CCHT) is focused on performing research and providing service. Our team develops and promotes genetic testing assays in the field of assisted reproductive biology as well as in all obstetrical and gynecological clinics. The laboratory also provides other advanced genetic testing services such as non-invasive prenatal genetic testing NIPT (www.niptify.ee) and preimplantation genetic screening (PGT-A). The NIPTIFY is reimbursed by Estonia social security fund since January 2020. That is why NIPTIFY test is a market leader NIPT in Estonia. CCHT is an approved service provider by an Estonian Health Board with a license number L05235.

Laboratory quality and approvals

beREADY technology is unique and patented. Biomarker molecules are analyzed by patented TAC-seq sequencing technology that ensures ultimate accuracy.
Our laboratory has ISO 15189 certification in the field of genomics.
Laboratory participates regulary in an independence and international EMQN quality assurance scheme.
We operate under Health Board permission number L05235 in the field of molecular diagnostics.